The PurpleLab^® Resource Center

How do healthcare marketers prove ROAS beyond the vanity metrics of clicks, impressions and website conversions? With new and emerging solutions for outcomes-based measurement in the healthcare industry, what metrics should healthcare marketers be using?

This research, led by Grace K. Kane, Douglas Londono, and Nathan J. Markward, explores how the timing of biomarker testing affects survival outcomes in patients with non-small cell lung cancer (NSCLC). Using real-world claims data, it identifies disparities in testing and treatment patterns and their impact on mortality rates. Biomarker testing is essential to advancing…

Headache disorders including migraine are highly prevalent globally, estimated to affect more than 50% of the population at any point and time. In the U.S., migraine patients spend an average of $9,000 more than those without the diagnosis.